Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 50% Gains Investing -- Ignore unavailable to you. Want to Upgrade?

To: Richard Tsang who wrote (15435)	2/8/2000 12:28:00 AM
From: Dale Baker	Read Replies (1) \| Respond to of 118717

That's terrific, Rich. I was so fed up today listening to the CNBC crowd whine about why the market internals and technical indicators don't make the "experts" happy, yada yada yada. And here are ordinary folks blowing away the averages and all the top funds through good stockpicking. I will hang onto BOSC if it doesn't break below its recent trading range. It would certainly get bought by MSFT for $20 the day after I sell it, so I will hang on and condemn the poor company to a few more months of single digits. Once BOSC does get thru 9 it should move up a few more points very quickly.

To: Richard Tsang who wrote (15435)	2/8/2000 6:45:00 AM
From: JSB	Read Replies (2) \| Respond to of 118717

Congrats Rich, glad to have helped. <gg> You owe me another pick like ADAP, but make sure I buy it. LOL For a biotech, BINC is still undervalued, even without GRAS. OTOH, there has been some speculation that some of the accumulation is from a big boy intent on buying BINC outright. Who knows. What is interesting is that the float is rapidly drying up with the volume in the last few weeks. 10 mil shares total, 4 mil held by the Levins and a few insiders, about 1 mil held by institutions and 1/2 mil short. That leaves an effective float of 4 1/2 mil shares, most of which are owned by you and me, right? <vbg> Jeff